Literature DB >> 10853034

Alteration of tumor phenotypes of B16 melanoma after genetic remodeling of the ganglioside profile.

T Tsurifune1, T Ito, X J Li, S Yamashiro, M Okada, T Kanematsu, H Shiku, K Furukawa.   

Abstract

Gangliosides have been thought to be tumor markers of various neuroectoderm-derived cancers. However, their roles in malignant phenotypes of cancer cells are not well understood. We have performed the remodeling of ganglioside profiles of mouse melanoma B16 (B78 subline) by introducing GM2/GD2 synthase cDNA, and analyzed the phenotypic changes such as cell morphology, growth, adhesion and c-fos gene expression. Although newly expressed GM2 was clearly detected, GM2-positive transfectant cells showed rather reduced growth rates in vivo and in vitro, lower expression levels of c-fos gene and increased levels of cell adhesion to extracellular matrices compared to control cells. These results suggested that GM2 is involved in the regulation of cell-cell or cell-extracellular matrix interaction, and negatively control cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853034

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

Review 1.  Signaling domains of cancer-associated glycolipids.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Kazunori Hamamura; Yuji Kondo; Yuki Ohkawa; Kei Kaneko; Noboru Hashimoto; Farhana Yesmin; Robiul H Bhuiyan; Orie Tajima; Keiko Furukawa
Journal:  Glycoconj J       Date:  2022-03-22       Impact factor: 2.916

2.  Raft-based interactions of gangliosides with a GPI-anchored receptor.

Authors:  Naoko Komura; Kenichi G N Suzuki; Hiromune Ando; Miku Konishi; Machi Koikeda; Akihiro Imamura; Rahul Chadda; Takahiro K Fujiwara; Hisae Tsuboi; Ren Sheng; Wonhwa Cho; Koichi Furukawa; Keiko Furukawa; Yoshio Yamauchi; Hideharu Ishida; Akihiro Kusumi; Makoto Kiso
Journal:  Nat Chem Biol       Date:  2016-04-04       Impact factor: 15.040

3.  Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis.

Authors:  Richard Jennemann; Giuseppina Federico; Daniel Mathow; Mariona Rabionet; Francesca Rampoldi; Zoran V Popovic; Martina Volz; Thomas Hielscher; Roger Sandhoff; Hermann-Josef Gröne
Journal:  Oncotarget       Date:  2017-11-24

Review 4.  New era of research on cancer-associated glycosphingolipids.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Yuki Ohkawa; Robiul H Bhuiyan; Pu Zhang; Orie Tajima; Noboru Hashimoto; Kazunori Hamamura; Keiko Furukawa
Journal:  Cancer Sci       Date:  2019-04-29       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.